BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17209351)

  • 1. [Neurotoxicity of cyclosporine].
    Kozłowska I; Rózańiski J; Ciechanowski K
    Wiad Lek; 2006; 59(7-8):516-20. PubMed ID: 17209351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine-A induced neurotoxicity after renal transplantation.
    Derici U; Arinsoy T; Sindel S; Tali T; Leventoglu A; Sert S
    Acta Neurol Belg; 2001 Jun; 101(2):124-7. PubMed ID: 11486560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cyclosporine-induced nephropathy in patients after heart transplantation -- a significant clinical problem].
    Dziewanowski K; Kurowski M; Kopeć E; Busz-Papiez B
    Kardiol Pol; 2006 May; 64(5):522-5. PubMed ID: 16752339
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
    Ahmadi F; Naseri R; Lessan-Pezeshki M
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical mechanisms of cyclosporine neurotoxicity.
    Serkova NJ; Christians U; Benet LZ
    Mol Interv; 2004 Apr; 4(2):97-107. PubMed ID: 15087483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine trough levels and its side effects in kidney transplant recipients.
    Hami M; Mojahedi MJ; Naghibi M; Shakeri MT; Sharifipour F
    Iran J Kidney Dis; 2010 Apr; 4(2):153-7. PubMed ID: 20404428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical neurologic illness in the immunocompromised patient.
    Cohen JA; Raps EC
    Neurol Clin; 1995 Aug; 13(3):659-77. PubMed ID: 7476823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine in Pediatric Nephrology.
    Arslansoyu Camlar S; Soylu A; Kavukçu S
    Iran J Kidney Dis; 2018 Nov; 12(6):319-330. PubMed ID: 30595561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine-induced white and grey matter central nervous system lesions in a pediatric renal transplant patient.
    Jeruss J; Braun SV; Reese JC; Guillot A
    Pediatr Transplant; 1998 Feb; 2(1):45-50. PubMed ID: 10084760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease after heart transplantation.
    Hamour IM; Omar F; Lyster HS; Palmer A; Banner NR
    Nephrol Dial Transplant; 2009 May; 24(5):1655-62. PubMed ID: 19168463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential diagnosis between rejection and cyclosporine toxicity.
    Mihatsch MJ; Ryffel B; Gudat F
    Kidney Int Suppl; 1995 Dec; 52():S63-9. PubMed ID: 8587287
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myelodysplastic syndrome with cyclosporine A-induced encephalopathy presenting with a mass effect on the right basal ganglia after cord blood transplantation].
    Koh H; Yamane T; Nakane T; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Nakamae H; Koh KR; Mochizuki K; Hayashi N; Hino M
    Rinsho Ketsueki; 2006 Dec; 47(12):1539-43. PubMed ID: 17233473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical blindness secondary to cyclosporine after orthotopic heart transplantation: a case report and review of the literature.
    Drachman BM; DeNofrio D; Acker MA; Galetta S; Loh E
    J Heart Lung Transplant; 1996 Nov; 15(11):1158-64. PubMed ID: 8956125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
    Chadban S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine-associated encephalopathy: a case report and literature review.
    Chang SH; Lim CS; Low TS; Chong HT; Tan SY
    Transplant Proc; 2001; 33(7-8):3700-1. PubMed ID: 11750577
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine induced neurotoxicity in a stem cell transplant recipient.
    Raza S; Ullah K; Ahmed P; Satti TM; Kamal MK; Chaudhry QU
    J Pak Med Assoc; 2007 Dec; 57(12):611-3. PubMed ID: 18173046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial hypertension in renal transplantation.
    Sandrini S; Gaggia P; Bracchi M; Gaggiotti M; Brunori G; Maiorca R
    Contrib Nephrol; 1996; 119():16-25. PubMed ID: 8783585
    [No Abstract]   [Full Text] [Related]  

  • 19. [Usefulness of the EEG recording in the diagnosis of cyclosporin A-induced encephalopathy].
    Sueiras M; González N; Rovira R; Padró L
    Rev Neurol; 1998 May; 26(153):766-9. PubMed ID: 9634664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?: case reports.
    Dzudie A; Boissonnat P; Roussoulieres A; Cakmak ; Mosbah K; Bejui FT; Obadia JF; Sebbag L
    Transplant Proc; 2009 Mar; 41(2):716-20. PubMed ID: 19328965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.